About
Dr. Agarwal’s Health Care is a leading provider of comprehensive eye care services, offering cataract, refractive, and other surgeries, consultations, diagnoses, and non-surgical treatments, along with opticals, contact lenses, and eye care-related pharmaceutical products. With a 25% market share in India’s eye care service chain market (FY24) and the largest network of 209 facilities as of September 30, 2024, their “hub and spoke” model ensures deeper reach and accessibility. Serving 2.13 million patients and performing over 220,000 surgeries in FY24, Dr. Agarwal’s healthcare caters to diverse needs through Primary, Secondary, and Tertiary Facilities, including three Centers of Excellence. Led by Dr Amar Agarwal and supported by institutional investors like Temasek and TPG, Dr Agarwal’s Health Care operates across 14 states in India and nine countries in Africa.
Issue size
| Funds Raised in the IPO |
Amount |
| Overall |
₹3027.26 crores |
| Fresh Issue |
₹300 crores |
| Offer for Sale |
₹2727.26 crores |
Utilisation of proceeds
| Purpose |
INR crores |
| Repayment/prepayment, in part or full, of certain borrowings |
195.00 |
|
|
Financials
Financial Snapshot
| Financial Year Ended |
March 2022 |
March 2023 |
March 2024 |
September 2024 |
| Total Assets |
1,026.13 |
1,825.17 |
2,752.82 |
3,393.41 |
| Revenue |
713.78 |
1,031.49 |
1,376.45 |
837.94 |
| Profit After Tax |
43.16 |
103.23 |
95.05 |
39.56 |
*All figures are in ₹ Crores.
Strengths
- Largest network of 209 eye care centers in India.
- Strong leadership and operational history.
- Comprehensive services and product offerings.
- Significant market share and growth potential.
Risks
- Dependency on regulatory approvals.
- Intense market competition.
- Financial and debt-related risks.
- Potential legal challenges.
Allotment Status for Dr. Agarwal’s Health Care
To check your allotment status - click here.
IPO schedule
| Issue open date |
2025-01-29 |
| Issue close date |
2025-01-31 |
| UPI mandate deadline |
2025-01-31 (5 PM) |
| Allotment finalization |
2025-02-03 |
| Refund initiation |
2025-02-04 |
| Share credit |
2025-02-04 |
| Listing date |
2025-02-05 |
| Mandate end date |
2025-02-13 |
| Lock-in end date for anchor investors (50%) |
2025-03-05 |
| Lock-in end date for anchor investors (remaining) |
2025-05-04 |
2 Likes